Duopharma Biotech Bhd 2025 Integrated Report
Company: Duopharma Biotech Bhd
Sector: Manufacturing
Country: Malaysia
Year: 2025
Type: Integrated Report
Pages: 272
The report highlights Duopharma Biotech's strong FY2025 performance, including revenue of RM931.69 million and continued growth across its pharmaceutical businesses. Sustainability highlights include a 2% year-on-year decrease in Scope 1 and 2 GHG emissions, 3.2 GWh of solar generation, 28% replacement of single-use plastics with biodegradable alternatives, and 6,116m3 of recycled water. The Group adopted dual materiality and prioritised 11 material sustainability matters, while the Board and Halal and Sustainability Committee continued to oversee sustainability. Social and governance achievements included 2,001 employees, zero workplace fatalities, zero corruption incidents and expanded diversity initiatives.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.